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Abstract
The optimal method of thromboprophylaxis and the value of screening ultrasonography for detection of deep venous
thrombosis (DVT) in neurosurgery patients remains unclear. The goal of this study was to determine the incidence
of DVT in neurosurgical patients who, by hospital protocol, receive surveillance ultrasonography of the lower
extremities twice weekly, in addition to prophylaxis with unfractionated heparin and external pneumatic
compression sleeves. A retrospective review of 7,298 ultrasound studies carried out on 2,593 patients over four
years at a university neurosurgical hospital was conducted. There was a 7.4% incidence of proximal lower
extremity DVT and a 9.7% total incidence including distal DVT. A greater number of distal DVTs were detected
with the implementation of whole-leg ultrasonography in the last two years of observation. Chart review of 237
patients diagnosed with DVT demonstrated an admitting diagnosis of subarachnoid hemorrhage in nearly half of the
patients. The median hospital length of stay for DVT patients was 18 days. Institutional control data demonstrated
non-ruptured aneurysm and cerebrovascular anomalies to be the leading reason for admission, followed closely by
subarachnoid hemorrhage. The hospital protocol of biweekly screening ultrasound and dual modality prophylaxis
for neurosurgery patients resulted in a proximal DVT incidence consistent with that demonstrated by previous
studies of standardized dual modality prophylaxis, and higher than that demonstrated in previous studies that
employed ultrasound screening protocols.
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Introduction
Venous thromboembolism (VTE) is a diagnostic term that encompasses deep vein thrombosis (DVT) and its most
serious complication, pulmonary embolism (PE). Best estimates are that 350,000 to 600,000 Americans develop
VTE each year, with PE causing 180,000 deaths annually [1]. Indeed, PE is the number one cause of preventable
death in hospitalized patients [2]. There are many published guidelines for VTE prophylaxis, of which those from
the American College of Chest Physicians (ACCP) are the most widely used [3]. Yet, only 62% of patients
undergoing major surgical procedures at risk for VTE are receiving ACCP-recommended prophylaxis globally [4].
The high incidence of hospital-acquired VTE demonstrates the current gap between evidence-based prophylaxis
guidelines and quality measure implementation [5].
Patients undergoing neurosurgery are considered to be at moderate risk for VTE [2], with the rate of DVT
for combined cranial/spinal procedures performed without prophylaxis varying from 29 to 43% [6]. However,
patients with spinal cord injury, malignancy, increasing age, cardiac or respiratory failure, prolonged immobility,
and a wide variety of inherited and acquired hematologic conditions are at considerably higher risk [7]. The optimal
method of VTE prophylaxis in neurosurgical patients is a matter of controversy. The landmark 1998 study by
Agnelli et al. demonstrated the superiority of combined pharmacologic and mechanical prophylaxis over mechanical
methods alone in neurosurgical patients, reducing the risk of VTE from 33 to 17% [8]. Several subsequent studies
have similarly reported lower rates of VTE with multimodality prophylaxis [9,10]. However, some neurosurgeons
do not use heparin for peri-procedural prophylaxis secondary to concerns of significant bleeding complications [11].
In 2005, Danish et al. compared the safety and efficacy of pharmacologic anticoagulants with mechanical
prophylaxis for craniotomy patients using decision analysis computer modeling to simulate virtual trials based on
statistics from published literature [12]. Modeling suggested that the addition of heparin lowered the incidence of
both DVT and PE, but at the cost of increasing the rate of intracranial hemorrhage (ICH). The authors concluded
that the deleterious effects of ICH are greater than the benefits from pharmacologic anticoagulation on VTE
morbidity and mortality, and that overall outcomes are best with mechanical prophylaxis alone. A meta-analysis
conducted in 2008 support the findings by Danish et al [13].
The current ACCP guidelines recommend that mechanical prophylaxis, using intermittent pneumatic
compression devices, be used in neurosurgical patients [2]. Acceptable alternatives to intermittent pneumatic
compression devices include postoperative low molecular weight heparin (LMWH) or perioperative low dose

4

unfractionated heparin. For patients who have a particularly high risk of thrombosis, combined mechanical and
pharmacologic methods are recommended.
Another area of debate in VTE prophylaxis is surveillance ultrasonography for postoperative neurosurgery
patients. The evidence base upon with which standardized DVT surveillance protocols or guidelines can be created
is lacking. The natural history of incidentally discovered, asymptomatic DVT is unclear. It is possible that these
have a lower propensity to propagate or embolize, and that aggressive treatment in a high bleeding-risk population
may provide more harm than benefit.

The question of the correct frequency of surveillance screening in

neurosurgical patients, or if it should be performed at all, remains unanswered.
The objective of the current study was to retrospectively assess the incidence of lower extremity DVT, as
diagnosed by surveillance compression ultrasonography (US), in the setting of a dual modality prophylaxis regimen
aimed at minimizing VTE among neurosurgical patients at the Jefferson Hospital for Neuroscience (JHN) over a
four year time period.
JHN is a free-standing university neurosurgical specialty hospital where the standard of care is for patients
who are not actively being treated for DVT to have surveillance ultrasound twice weekly, regardless of their clinical
status, mobility, diagnosis, or symptoms. In addition, the standard of care calls for all neurosurgical patients to
receive, within twenty-four hours of hospitalization, prophylaxis with external pneumatic compression sleeves and
unfractionated heparin (UFH) 5000 units (U) every 12 hours.

Methods
A retrospective review of ultrasound database records for all neurosurgical patients admitted who had
compression ultrasound surveillance of the lower extremity during the four year study period, from January 2003
and December 2006, was completed. Total number of lower extremity ultrasound studies performed as well as
positivity for lower extremity DVT was collected. Distal (calf vein) versus proximal (popliteal, branches of femoral,
or external iliac vein) location of the DVT was recorded.
Prior to 2005, the distal lower extremity was not routinely examined during surveillance ultrasound. In the
last two years of the data collection period, a change to the standard ultrasound technique in was made to include the
entire lower extremity, capturing images from the iliac to calf veins and thereby allowing for detection of distal
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DVT. All upper extremity ultrasound studies were excluded from review. Each patient was counted only once for
DVT occurrence during the entire study period, regardless of their number of positive ultrasound scans.
Electronic chart review was possible for 237 of 252 patients identified as positive for lower extremity DVT
over the four year study period. Data was collected on dates of admission and discharge, as well as primary
diagnosis, for these 237 patientsAt the time of this study, the medical records in our system were partially
computerized and partially paper. As a result, collection of more comprehensive data on each patient was limited.
Administrative hospital data was used to estimate an approximate case mix of all patients admitted to the
neurosurgical services.

Results
A total of 7,298 ultrasound studies performed on the lower extremities of 2,593 patients were eligible for
analysis (Table 1). Of these patients, 252 (9.7%) were found to have proximal and/or distal lower extremity DVT
(Figure 1; Table 2). The number of patients with proximal lower extremity DVT alone was 193 (7.4%). The age
distribution of patients with DVT was 18 to 97 years, with a mean age of 61. Of DVT patients, 42% were male and
58% were female. Three distal DVTs were detected in 2003-04, while 56 were detected in the 2005-06. While
direct case controls without thrombosis were not available due to the nature of the database search method used,
hospital-wide census data revealed a mean patient age of approximately 56 years old.
For 237 patients identified with DVT, subarachnoid hemorrhage was the leading primary diagnosis,
accounting for 48.5% of cases. ICH was the reason for admission in 11.8% of DVT patients, 11% were admitted
with malignancy, and 8.9% with non-ruptured cerebral aneurysm and cerebrovascular anomalies (Table 3). Among
the general neurosurgical population admitted to JHN, the approximate case mix revealed non-ruptured cerebral
aneurysm and cerebrovascular anomalies accounted for approximately 30% of admissions, followed by 24% SAH,
8% ICH and 7% malignancy. The DVT population in this study had a larger proportion of patients admitted with
SAH, ICH or malignancy as primary diagnosis, and significantly fewer patients admitted with non-ruptured
aneurysms, when compared to hospital-wide data.
The median length of stay for DVT patients reviewed was 18 days. There was a trend toward decreasing
length of stay observed over the four year time period. Compared to these hospital-wide patient data, DVT patients
had longer lengths of stay regardless of primary diagnosis. Most notably, patients with non-ruptured cerebral
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aneurysms and cerebrovascular anomalies who developed DVTs had longer lengths of stay than other patients with
the same diagnosis.

Discussion
The reported incidence of DVT in neurosurgical patients varies widely. The biweekly screening protocol
revealed an overall incidence of 7.4% proximal lower extremity DVT and 9.7% total lower extremity DVT in
neurosurgical patients where the hospital protocol was to administer prophylaxis with UFH 5,000 U twice daily and
external pneumatic compression sleeves within 24 hours of admission.
The proximal DVT rate in our study is consistent with data published from a number of other studies.
Nurmohamed et al. examined the incidence of both proximal and total lower extremity DVT in neurosurgical
patients.

Patients in that study received LMWH (nadroparin) and graduated compression stockings, and by

venography were found to have a proximal lower extremity incidence of 7%; however, the incidence of total lower
extremity DVT was considerably higher at 19% [14]. Similarly, Agnelli et al. demonstrated an incidence of 5%
proximal and 17% total lower extremity DVT, in patients treated with both LMWH (enoxaparin) and compression
stockings as detected by venography at treatment day 8 (or sooner if the patient developed symptoms of DVT
confirmed by compression ultrasound) [8]. Both of these studies revealed a significant reduction in the rate of DVT
when combined prophylactic regimens were employed. In comparison, our study demonstrated a much smaller
proportion of distal DVTs detected.

Whole-leg ultrasound was not practiced in the first two years of our

investigation which contributed to lower overall rates of distal DVT. The lower percentage of distal DVT may also
be due, in part, to decreased sensitivity of ultrasound when compared to venography employed in the above studies.
It is also possible that operator variability, technically limited calf studies, or a learning curve related to change in
ultrasound procedure led to decreased detection of calf vein DVT in 2005 and 2006, when whole leg
ultrasonography was being practiced.
In 2002, Goldhaber et al. used a multimodality prophylactic regimen of enoxaparin 40 mg/dl or UFH 5,000
U twice daily, graduated compression stockings, intermittent pneumatic compression stockings, and one predischarge venous ultrasound study of the legs in 150 craniotomy patients [10]. This approach resulted in no patients
with symptomatic DVT, but a total lower extremity asymptomatic DVT incidence of 9.3%, very similar to our 9.7%
rate of total lower extremity DVT. We were unable to determine symptomatic vs. asymptomatic DVT as our
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investigation was a retrospective review of an ultrasound database, and documentation in the charts reviewed was
such that it was not able to be clearly determined. Based on our population and prior studies, we assume the large
majority were asymptomatic and detected by the biweekly screening protocol.
Depending on the severity of their condition, many neurosurgical patients may not exhibit signs or express
symptoms of thrombosis, so surveillance ultrasound may play a unique role in the early detection of DVT and
prevention of PE in this patient population. However, there is conflicting data in the literature regarding propagation
rates and long-term clinical significance of distal (calf vein) DVT and the appropriate management of these cases
[15-17]. Screening ultrasound in neurosurgery patients increases diagnosis of asymptomatic calf vein DVT and
furthers the debate on appropriate management of these patients at increased risk for intracranial hemorrhage.
Hence, it is clear that more large scale prospective studies are needed to help address this issue.
In a similar fashion to our described prophylaxis and surveillance protocol, Misra et al. reviewed routine
ultrasound performed twice weekly on 1,094 patients admitted to a neurosurgical intensive care unit [18]. All of
these patients were administered DVT prophylaxis in the form of UFH 5000 U twice daily and sequential
compression boots at all times until patients were able to ambulate. The incidence of DVT was 2.55% compared to
5.62% in patients of all other ICUs within the same hospital that did not adhere to a strict prophylactic regimen or
screening protocol. Furthermore, there was a very low progression of DVT to PE in the neurosurgical intensive care
patients (3.6%) compared to patients in all other intensive care units (19%), suggesting that the neurosurgical
intensive care bi-weekly screening protocol helped in the early detection of DVT and prevention of PE. Compared
to these studies, the incidence of DVT in our study is higher. This may be related to the larger examined patient
population in our study, or possibly a larger proportion of high-risk patients.
Whether it is cost-effective to be screening all neurosurgical patients twice weekly is still unclear. This
type of screening protocol employed by Misra et al. was estimated to cost between $1,300 to $1,800 per week.18 It
may be advantageous to follow a screening protocol such as this in only those neurosurgical patients at particularly
high-risk. For example, a study of 2,643 neurosurgical patients demonstrated a 7.7% incidence of DVT with routine
screening in patients undergoing cranial surgery, but only a 1.5% incidence in spinal surgery patients [19]. The
authors suggested that only craniotomy patients require routine screening. Similarly, Ray et al. identified patients
who suffered aneurysmal subarachnoid hemorrhage as being a high-risk group for DVT development, having a 24%
incidence of asymptomatic DVT [20]. The benefit of routine screening in these high-risk groups, and others like
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them, likely outweighs concerns of cost-effectiveness. Our results indicate that SAH is one of the most common
primary diagnoses at our institution, and in the vast majority of those patients identified with DVT in this study,
hence we feel this patient population is generally high-risk, favoring the prophylaxis and surveillance
ultrasonography protocol we employ.
There are a number of limitations to this investigation, including its retrospective nature. Mortality,
bleeding complication rates, incidence of PE, and the number of diagnostic studies for PE ordered in patients with
DVT were not obtained due to the nature of the database employed. Other limitations include an unknown number
of patients therapeutically anticoagulated at presentation, or with a prior history of DVT.

Patients received a

standardized therapy, and there was no control group against which to compare management approaches.
Furthermore, the standard of care at JHN calls for all neurosurgical patients to receive, within twenty-four hours of
hospitalization, prophylaxis with external pneumatic compression sleeves and UFH 5000 units every 12 hours, but
it is possible that deviation from this prophylaxis protocol impacted our rates of DVT.
Obtaining individual demographic information for those patients screened and found to be negative for
DVT was beyond the scope of our study. Accordingly, a separate database, which included cases and controls, was
used to establish general trends among all patients admitted to JHN for a period of time during our study. Finally,
the case mix of this hospital is unique in that it is a free-standing neurosurgical hospital specializing in aneurysm and
SAH management, so the generalizability of our data may be limited.
In conclusion, the biweekly screening protocol and dual modality prophylaxis regimen employed in this
large neurosurgical population of 2,593 patients over four years, dominated by patients with cerebral aneurysms and
SAH, yielded a total DVT incidence of 9.7%. Proximal DVT incidence of 7.4% is consistent with that demonstrated
by previous studies of standardized dual modality prophylaxis, and higher than that demonstrated in previous studies
additionally employing routine screening ultrasound protocols. The use of screening ultrasonography protocols is
still debated, and further investigation into whether it is useful and cost-effective to performing screening
ultrasounds routinely or in selected high-risk groups within the neurosurgical population is warranted.

Acknowledgements
The authors would like to thank Daniel Louis and Megan Templin for assistance in obtaining hospital data.

9

References
1. The Surgeon General's Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism. U.S.
Department of Health and Human Services [Internet] 2008 [cited 2010 Nov 6]. Available from:
http://www.surgeongeneral.gov/topics/deepvein/calltoaction/call-to-action-on-dvt-2008.pdf
2. Geerts WH, Bergqvist D, Pineo GF, et al (2008) Prevention of venous thromboembolism: American College of
Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133(6 Suppl): 381S-453S.
3. Hirsh J, Guyatt G, Albers GW, Harrington R, Schunemann HJ, American College of Chest Physician (2008)
Antithrombotic and thrombolytic therapy: American College of Chest Physicians Evidence-Based Clinical Practice
Guidelines (8th Edition). Chest 133(6 Suppl): 110S-112S.
4. Kakkar AK, Cohen AT, Tapson VF, et al (2010) Venous thromboembolism risk and prophylaxis in the acute care
hospital setting (ENDORSE survey): findings in surgical patients. Ann Surg 251(2): 330-338.
5. Deitelzweig SB, Lin J, Hussein M, Battleman D (2009) Are surgical patients at risk of venous thromboembolism
currently meeting the Surgical Care Improvement Project performance measure for appropriate and timely
prophylaxis? J Thromb Thrombolysis 30(1): 55-66.
6. Black PM, Baker MF, Snook CP (1986) Experience with external pneumatic calf compression in neurology and
neurosurgery. Neurosurgery 18(4): 440-444.
7. Anderson FA,Jr, Spencer FA (2003) Risk factors for venous thromboembolism. Circulation 107(23 Suppl 1):I916.
8. Agnelli G, Piovella F, Buoncristiani P, et al (1998). Enoxaparin plus compression stockings compared with
compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. N Engl J
Med 339(2): 80-85.
9. Iorio A, Agnelli G (2000) Low-molecular-weight and unfractionated heparin for prevention of venous
thromboembolism in neurosurgery: a meta-analysis. Arch Intern Med 160(15): 2327-2332.
10. Goldhaber SZ, Dunn K, Gerhard-Herman M, Park JK, Black PM (2002) Low rate of venous thromboembolism
after craniotomy for brain tumor using multimodality prophylaxis. Chest 122(6): 1933-1937.
11. Gnanalingham KK, Holland JP (2003) Attitudes to the use of prophylaxis for thrombo-embolism in
neurosurgical patients. J Clin Neurosci 10(4): 467-469.
12. Danish SF, Burnett MG, Ong JG, Sonnad SS, Maloney-Wilensky E, Stein SC (2005) Prophylaxis for deep
venous thrombosis in craniotomy patients: a decision analysis. Neurosurgery 56(6): 1286-1294.
13. Collen JF, Jackson JL, Shorr AF, Moores LK (2008) Prevention of venous thromboembolism in neurosurgery: a
metaanalysis. Chest 134(2): 237-249.
14. Nurmohamed MT, van Riel AM, Henkens CM, et al (1996) Low molecular weight heparin and compression
stockings in the prevention of venous thromboembolism in neurosurgery. Thromb Haemost 75(2): 233-238.

10

15. Bernardi E, Camporese G, Buller HR, et al (2008) Serial 2-point ultrasonography plus D-dimer vs whole-leg
color-coded Doppler ultrasonography for diagnosing suspected symptomatic deep vein thrombosis: a randomized
controlled trial. JAMA 300(14): 1653-1659.
16. MacDonald PS, Kahn SR, Miller N, Obrand D (2003) Short-term natural history of isolated gastrocnemius and
soleal vein thrombosis. J Vasc Surg 37:523-527.
17. Gillet JL, Perrin MR, Allaert FA (2007) Short-term and mid-term outcome of isolated symptomatic muscular
calf vein thrombosis. J Vasc Surg 46:513-519.
18. Misra M, Roitberg B, Ebersole K, Charbel FT (2004) Prevention of pulmonary embolism by combined
modalities of thromboprophylaxis and intensive surveillance protocol. Neurosurgery 54 (5):1099-1103.
19. Flinn WR, Sandager GP, Silva MB,Jr, Benjamin ME, Cerullo LJ, Taylor M (1996) Prospective surveillance for
perioperative venous thrombosis: experience in 2643 patients. Arch Surg 131(5):472-480.
20. Ray WZ, Strom RG, Blackburn SL, Ashley WW, Sicard GA, Rich KM (2009) Incidence of deep venous
thrombosis after subarachnoid hemorrhage. J Neurosurg 110(5):1010-1014.

11

Table 1 Compression ultrasound studies performed

Total lower extremity studies

2003
1786

2004
1905

2005
1878

2006
1729

Total
7298

Patients with lower extremity studies

505

625

747

716

2593

Mean studies per patient

3.5

3.1

2.5

2.4

2.8
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Figure 1 Incidence of lower extremity DVT
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Table 2 Incidence of lower extremity DVT
2003

2004

2005

2006

Total

Patients with lower extremity DVT

7.3%

10.1%

9.1%

11.7%

9.7%

Patients with proximal DVT

7.1%

9.8%

6.0%

7.1%

7.4%

Patients with distal only DVT

0.2%

0.3%

3.1%

4.6%

2.3%
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Table 3 Primary diagnosis among DVT patients
Primary Diagnosis

Total patients

Percent patients

SAH

115

48.5%

ICH

28

11.8%

Malignancy

26

11.0%

Unruptured aneurysm/AVM1

21

8.9%

Mass/tumor

11

4.6%

Other2

36

15.2%

1 Arteriovenous malformation, cerebrovascular anomaly
2 Most common diagnoses were infection, hydrocephalus, mental status change, and seizure.

